Physician profile
Cheryl A Johnson
NPI 1417066671
$9,169.42
in general payments reported to CMS, 2019-2025
72 companies · $933 in 2025
The $933 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,897 · 2020: $930 · 2021: $1,766 · 2022: $1,150 · 2023: $1,218 · 2024: $1,275 · 2025: $933.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,226 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,225.99 |
| Education | $199.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,352.95 | 2019-2025 | |
| Astellas Pharma US INC | $1,019.57 | 2019-2025 | Veozah, Myrbetriq |
| Astrazeneca Pharmaceuticals LP | $674.76 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Novartis Pharmaceuticals Corporation | $548.89 | 2019 | |
| Lilly USA, LLC | $447.06 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $425.94 | 2019-2025 | |
| Antares Pharma, INC. | $410.50 | 2019-2023 | Tlando, Xyosted, Nocdurna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $294.81 | 2019-2025 | Jardiance |
| Ironshore Pharmaceuticals INC. | $256.50 | 2019-2024 | Jornay Pm |
| Sanofi-Aventis U.S. LLC | $230.13 | 2019-2023 | |
| Amgen INC. | $225.36 | 2020-2025 | Evenity, Prolia, Otezla |
| Allergan, INC. | $209.02 | 2019-2020 | |
| Glaxosmithkline, LLC. | $205.49 | 2019-2025 | Shingrix, Arexvy, Bexsero |
| Tris Pharma INC | $193.72 | 2019-2025 | Dyanavel Xr |
| Janssen Pharmaceuticals, INC | $159.43 | 2019-2023 | Xarelto |
Show all 72 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.